SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001683168-24-004799
Filing Date
2024-07-12
Accepted
2024-07-12 16:30:47
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-1 cns_s1.htm S-1 245539
2 OPINION OF ARENTFOX SCHIFF, LLP cns_ex0501.htm EX-5.1 7410
3 CONSENT cns_ex2301.htm EX-23.1 2919
4 FILING FEE TABLE cns_ex107.htm EX-FILING FEES 12577
5 GRAPHIC image_001.jpg GRAPHIC 7450
6 GRAPHIC image_002.jpg GRAPHIC 3239
  Complete submission text file 0001683168-24-004799.txt   284477
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-280790 | Film No.: 241114883
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)